Compare IRON & ATKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | ATKR |
|---|---|---|
| Founded | 2017 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2020 | 2016 |
| Metric | IRON | ATKR |
|---|---|---|
| Price | $59.06 | $58.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $103.18 | $75.67 |
| AVG Volume (30 Days) | ★ 520.9K | 261.6K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | ★ $2,850,378,000.00 |
| Revenue This Year | N/A | $6.76 |
| Revenue Next Year | $283.52 | $3.65 |
| P/E Ratio | ★ N/A | $127.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.82 | $49.92 |
| 52 Week High | $99.50 | $80.06 |
| Indicator | IRON | ATKR |
|---|---|---|
| Relative Strength Index (RSI) | 39.24 | 41.11 |
| Support Level | $57.81 | $55.25 |
| Resistance Level | $64.00 | $66.25 |
| Average True Range (ATR) | 2.81 | 1.92 |
| MACD | 0.08 | -0.14 |
| Stochastic Oscillator | 16.99 | 47.61 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Atkore Inc is a manufacturer of Electrical products for the non-residential construction and renovation markets, as well as residential markets, and Safety & Infrastructure products for the construction and industrial markets. The Electrical segment manufactures products used in the construction of electrical power systems including conduit, cable, and installation accessories. This segment serves contractors in partnership with the electrical wholesale channel. The Safety & Infrastructure segment designs and manufactures solutions including metal framing, mechanical pipe, perimeter security, and cable management. These solutions are marketed to contractors, original equipment manufacturers (OEMs), and end-users. The majority of revenue is generated from the Electrical segment.